Marin F - Search Results

1

Epidemiology and impact of frailty in patients with atrial fibrillation in Europe.

Proietti M, Romiti GF, Vitolo M, Harrison SL, Lane DA, Fauchier L, Marin F, Näbauer M, Potpara TS, Dan GA, Maggioni AP, Cesari M, Boriani G, Lip GYH; ESC-EHRA EORP-AF General Long-Term Registry Investigators. Proietti M, et al. Among authors: marin f. Age Ageing. 2022 Aug 2;51(8):afac192. doi: 10.1093/ageing/afac192. Age Ageing. 2022. PMID: 35997262 Free article.

2

Do protein Z levels influence the prothrombotic state in atrial fibrillation?

Marco P, Marín F, García A, Roldán V, Lip GY. Marco P, et al. Among authors: marin f. Thromb Res. 2002 May 15;106(4-5):269-70. doi: 10.1016/s0049-3848(02)00142-1. Thromb Res. 2002. PMID: 12297137 No abstract available.

3

Is thrombogenesis in atrial fibrillation related to matrix metalloproteinase-1 and its inhibitor, TIMP-1?

Marín F, Roldán V, Climent V, Garcia A, Marco P, Lip GY. Marín F, et al. Stroke. 2003 May;34(5):1181-6. doi: 10.1161/01.STR.0000065431.76788.D9. Epub 2003 Mar 27. Stroke. 2003. PMID: 12663879

4

Fibrinolytic function and atrial fibrillation.

Marín F, Roldán V, Lip GY. Marín F, et al. Thromb Res. 2003 Mar 15;109(5-6):233-40. doi: 10.1016/s0049-3848(03)00259-7. Thromb Res. 2003. PMID: 12818244 Review.

5

Interleukin-6, endothelial activation and thrombogenesis in chronic atrial fibrillation.

Roldán V, Marín F, Blann AD, García A, Marco P, Sogorb F, Lip GY. Roldán V, et al. Among authors: marin f. Eur Heart J. 2003 Jul;24(14):1373-80. doi: 10.1016/s0195-668x(03)00239-2. Eur Heart J. 2003. PMID: 12871695

6

Soluble E-selectin in cardiovascular disease and its risk factors. A review of the literature.

Roldán V, Marín F, Lip GY, Blann AD. Roldán V, et al. Among authors: marin f. Thromb Haemost. 2003 Dec;90(6):1007-20. doi: 10.1160/TH02-09-0083. Thromb Haemost. 2003. PMID: 14652631 Review.

7

Matrix metalloproteinases in atrial fibrillation.

Marín F, Roldán V, Climent V, Lip GY. Marín F, et al. J Am Coll Cardiol. 2004 Jan 7;43(1):152; author reply 152-3. doi: 10.1016/j.jacc.2003.10.019. J Am Coll Cardiol. 2004. PMID: 14715200 Free article. No abstract available.

8

Factor XIII Val34Leu polymorphism modulates the prothrombotic and inflammatory state associated with atrial fibrillation.

Marín F, Corral J, Roldán V, González-Conejero R, del Rey ML, Sogorb F, Lip GY, Vicente V. Marín F, et al. J Mol Cell Cardiol. 2004 Sep;37(3):699-704. doi: 10.1016/j.yjmcc.2004.06.001. J Mol Cell Cardiol. 2004. PMID: 15350843

9

A pharmacogenetic effect of factor XIII valine 34 leucine polymorphism on fibrinolytic therapy for acute myocardial infarction.

Marín F, González-Conejero R, Lee KW, Corral J, Roldán V, López F, Sogorb F, Caturla J, Lip GY, Vicente V. Marín F, et al. J Am Coll Cardiol. 2005 Jan 4;45(1):25-9. doi: 10.1016/j.jacc.2004.09.051. J Am Coll Cardiol. 2005. PMID: 15629368 Free article.

10

Relation of interleukin-6 levels and prothrombin fragment 1+2 to a point-based score for stroke risk in atrial fibrillation.

Roldán V, Marín F, Martínez JG, García-Herola A, Sogorb F, Lip GY. Roldán V, et al. Among authors: marin f. Am J Cardiol. 2005 Apr 1;95(7):881-2. doi: 10.1016/j.amjcard.2004.12.016. Am J Cardiol. 2005. PMID: 15781023

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

1,128 results

Search Page